Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB04946"

PredicateValue (sorted: default)
rdfs:label
"Iloperidone"
rdf:type
drugbank:drugs
drugbank:description
"Iloperidone is an atypical antipsychotic for the treatment of schizophrenia symptoms. Hoechst Marion Roussel Inc. made initial inquiries into the drug; however, in May 1996, they discontinued research, and in June 1997 gave research rights to Titan Pharmaceuticals. Titan then handed over worldwide development, manufacturing and marketing rights to Novartis in August 1998. On June 9, 2004, Titan Pharmaceuticals announced that the Phase III development rights have been acquired by Vanda Pharmaceuticals. FDA approved on May 9, 2009. "
drugbank:interactsWith
drug:Ziprasidone
drug:Fluoxetine
drug:Paroxetine
drug:Conivaptan
drug:Cocaine
drug:Ketoconazole
drug:Clarithromycin
drug:Zuclopenthixol
drug:Artemether
drug:Lumefantrine
drug:Zuclopenthixol acetate
drug:Zuclopenthixol decanoate
owl:sameAs
drug:Ziprasidone
drug:Fluoxetine
drug:Paroxetine
drug:Conivaptan
drug:Cocaine
drug:Ketoconazole
drug:Clarithromycin
drug:Zuclopenthixol
drug:Artemether
drug:Lumefantrine
drug:Zuclopenthixol acetate
drug:Zuclopenthixol decanoate

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines2/drugbank_small.nt

The resource appears as object in 24 triples

Context graph